Asymmetric Mannich Reactions
2359 2367
137.0, 129.4, 129.3, 127.3, 127.2, 62.7, 62.6, 61.8, 59.7, 32.5, 21.4, 13.8, 13.4, 7.8,
7.6; HRMS: calcd for C19H27NNaO7S: 436.1406; found: 436.1414 [MNa] .
13C NMR: d 208.3, 169.8, 169.1, 150.1, 143.7, 137.0, 129.6, 129.5, 127.4,
126.3, 121.2, 62.9, 62.1, 59.9, 32.6, 21.5, 20.2, 13.5, 7.9; HRMS: calcd for
C23H27NO7S: 484.1406; found: 484.1410 [MNa] .
Ethyl
3-methyl-4-oxo-3-(1-naphthyl)-methoxycarbonyl-2-(tosylamino)-
hexanoate (9b): The ee was determined by HPLC using a Daicel Chiralpak
AD column (hexane/iPrOH 80:20): flow rate 1.0 mLminÀ1: tmajor 7.3 min;
tminor 7.8 min; t2nd diast. 6.0 and 6.0 min). 1H NMR: d 8.00 (m, 1H,
ArH), 7.88 (m, 2H, ArH), 7.64 (m, 2H, ArH), 7.54 (m, 3H, ArH), 7.45 (m,
1H, ArH), 7.25 (m, 2H, ArH), 5.69 (d, J 22.3, 1H, OCH2Ar), 5.50 (d, J
22.3, 1H, OCH2Ar), 5.32 (d, J 10.1, 1H, NH), 4.36, (d, J 10.1, 1H, CH),
3.72 (m, 2H, OCH2), 2.67 (m, 1H, COCH2CH3), 2.36 (m, 1H, COCH2CH3),
2.41 (s, 3H, ArCH3), 1.62 (s, 3H, CCH3), 0.89 (t, J 7.3, 3H, COCH2CH3),
0.84 (t, J 7.0, 3H, OCH2CH3); 13C NMR: d 208.3, 170.9, 169.0, 143.5,
136.8, 133.6, 131.6, 130.4, 139.6, 129.4, 128.7, 128.0, 127.3, 126.6, 125.9, 125.2,
123.3, 66.1, 62.9, 61.9, 59.8, 32.5, 21.4, 20.0, 13.4, 7.7; HRMS: calcd for
Ethyl
3-methyl-4-oxo-3-adamantoxycarbonyl-2-(tosylamino)hexanoate
(9h): The ee was determined by HPLC using a Daicel Chiralpak AD
column (hexane/iPrOH 95:5): flow rate 1.0 mLminÀ1: tmajor 18.0 min;
tminor 13.0 min; t2nd diast. 9.2 and 11.8 min). [a]D À18.88 (c
52 mgmLÀ1, 90% ee); 1H NMR: d 7.73 (d, J 8.0, 2H, ArH), 7.28 (d,
J 8.0, 2H, ArH), 5.37 (d, J 10.0, 1H, NH), 4.30 (d, J 10.0, 1H, CH),
3.83 (q, J 6.8, 2H, OCH2CH3), 2.77 (m, 1H, COCH2CH3), 2.45 (m, 1H,
COCH2CH3), 2.41 (s, 3H, ArCH3), 2.18 (s, 3H, CH), 2.13 (s,6H, CH2), 1.66
(s, 6H, CH2), 1.57 (s, 3H, CCH3), 0.96, (t, J 7.4, 3H, OCH2CH3), 0.91 (t,
J 7.2, 3H, COCH2CH3); 13C NMR: d 208.7, 169.7, 169.2, 143.5, 137.0,
129.4, 127.4, 83.1, 63.4, 61.7, 59.8, 41.0, 36.0, 30.8, 21.4, 13.6, 8.0; HRMS:
C28H31NNaO7S: 548.1719; found: 548.1719 [MNa] .
calcd for C27H37NO7S: 542.2188, found: 542.2186 [MNa] .
Ethyl 3-methyl-4-oxo-3-(1'-isopropyl-2'-methyl-propanoxycarbonyl)-2-(to-
Ethyl
3-methyl-4-oxo-3-tert-butoxycarbonyl-2-(tosylamino)hexanoate
sylamino)hexanoate (9c): The ee was determined by HPLC using a Daicel
(9i): The ee was determined by HPLC using a Daicel Chiralpak AD
column (hexane/iPrOH 95:5): flow rate 1.0 mLminÀ1: tmajor 36.6 min;
tminor 22.6 min; t2nd diast. 14.4 and 38.1 min). [a]D À21.68 (c
43 mgmLÀ1, 92% ee); 1H NMR: d 7.73 (d, J 8.4, 2H, ArH), 7.28 (d,
J 8.4, 2H, ArH), 5.36 (d, J 10.4, 1H, NH), 4.31 (d, J 10.4, 1H, CH),
3.86 (q, J 7.3, 2H, OCH2CH3), 2.76 (m, 1H, COCH2CH3), 2.47 (m, 1H,
COCH2CH3), 2.41 (s, 3H, ArCH3), 1.58 (s, 3H, CCH3), 1.49 (s, 9H,
C(CH3)3), 1.03 (t, J 7.3, 3H, OCH2CH3), 0.96 (t, J 7.3, 3H, COCH2CH3);
13C NMR: d 208.6, 169.5, 169. 0, 143.5, 137.0, 129.4, 127.3, 82.9, 62.3, 61.6,
59.7, 32.5, 27.7, 21.4, 13.5, 7.9; HRMS: calcd for C21H31NNaO7S: 464.1719,
Chiralpak AD column (hexane/iPrOH 80:20): flow rate 1.0 mLminÀ1
:
tmajor 7.3 min; tminor 7.8 min; t2nd diast. 6.0 and 6.0 min). 1H NMR: d
7.73 (d, J 8.1, 2H, ArH), 7.29 (d, J 8.1, 2H, ArH), 5.50 (d, J 9.9, 1H,
NH), 4.67 (t, J 5.8, 1H, OCH(CH2)2), 4.44, (d, J 9.9, 1H, CH), 3.82 (m,
2H, OCH2), 2.71 (m, 1H, COCH2CH3), 2.41 (s, 3H, ArCH3), 1.93 (m, 1H,
CH(CH3)2), 1.67 (s, 1H, CH3), 1.04 (t, J 7.1, 3H, COCH2CH3), 0.92 0.83
(m, 15H, CH(CH3), OCH2CH3); 13C NMR: d 208.4, 170.9, 168.9, 143.5,
137.0, 129.4, 129.4, 127.3, 127.3, 84.9, 62.1, 61.8, 59.7, 32.4, 29.6, 29.5, 21.4,
19.7, 19.6, 17.5, 17.4, 13.5, 7.9, 7.7; HRMS: calcd for C24H37NO7S: 506.2188;
found: 506.2185 [MNa] .
found: 464.1715 [MNa] .
Ethyl 3-methyl-4-oxo-3-(9'H-fluoren-9'-oxycarbonyl)-2-(tosylamino)hexa-
noate (9d): The ee was determined by HPLC using a Daicel Chiralpak AD
column (hexane/iPrOH 95:5): flow rate 1.0 mLminÀ1: tmajor 58.4 min;
Ethyl
3-methyl-4-oxo-3-tert-butoxycarbonyl-2-(tosylamino)pentanoate
(11a): The ee was determined by HPLC using a Daicel Chiralpak AD
column (hexane/iPrOH 90:10): flow rate 1.0 mLminÀ1: tmajor 24.2 min;
tminor 16.0 min; t2nd diast. 11.4 and 26.5 min). [a]D À27.78 (c
38 mgmLÀ1, 88% ee); 1H NMR: d 7.73 (d, J 8.1, 2H, ArH), 7.28 (d,
J 8.1, 2H, ArH), 5.34 (d, J 9.9, 1H, NH), 4.33 (d, J 9.9, 1H, CH), 3.85
(m, 2H, OCH2CH3), 2.41 (s, 3H, ArCH3), 2.26 (s, 3H, COCH3), 1.59 (s, 3H,
CCH3), 1.49 (s, 9H, C(CH3)3), 0.96 (t, J 7.2, 3H, OCH2CH3); 13C NMR:
d 206.0, 169.7, 169.2, 143.5, 137.0, 129.5, 127.4, 83.1, 63.6, 61.8, 59.6, 27.8,
27.2, 21.5, 20.4, 13.6; HRMS: calcd for C20H29NNaO7S: 450.1562, found:
1
tminor 44.2 min; t2nd diast. 30.3 and 39.7 min). H NMR: d 7.75 7.27 (m,
10H, ArH), 6.80, (s, 1H, OCH), 5.42 (d, J 9.5, 1H, NH), 4.40 (d, J 9.5,
1H, CH), 3.87 (q, J 7.1, 2 H, OCH2CH3), 2.77 (m, 1H, COCH2CH3), 2.48
(m, 1H, COCH2CH3), 2.42 (s, 3H, ArCH3), 1.67 (s, 1H, CH3), 1.00 0.95
(m, 6H, OCH2CH3, COCH2CH3); 13C NMR: d 208.4, 171.9, 169.0, 143.5,
141.1, 141.1, 141.0, 140.9, 136.8, 129.6, 129.4, 127.8, 127.7, 127.3, 125.9, 125.7,
120.0, 76.3, 62.7, 61.9, 59.8, 32.5, 21.4, 20.2, 13.4, 1.8; HRMS: calcd for
C30H31NO7S: 572.1719; found: 572.1718 [MNa] .
450.1565 [MNa] .
Ethyl
3-methyl-4-oxo-3-cyclohexoxycarbonyl-2-(tosylamino)hexanoate
Ethyl 3,5-dimethyl-4-oxo-3-tert-butoxycarbonyl-2-(tosylamino)hexanoate
(11b): The ee was determined by HPLC using a Daicel Chiralpak AD
column (hexane/iPrOH 95:5): flow rate 1.0 mLminÀ1: tmajor 19.8 min;
tminor 14.2 min; t2nd diast. 11.9 and 32.4 min). [a]D À10.88 (c
38 mgmLÀ1, 91% ee); 1H NMR: d 7.75 (d, J 8.1, 2H, ArH), 7.29 (d,
J 8.1, 2H, ArH), 5.34 (d, J 9.9, 1H, NH), 4.31 (d, J 9.9, 1H, CH), 3.85
(m, 2H, OCH2CH3), 3.09 (q, J 6.5, 1H, COCH(CH3)2), 2.41 (s, 3H,
ArCH3), 1.64 (s, 3H, CCH3), 1.48 (s, 9H, C(CH3)3), 1.10 (d, J 6.9, 3H,
CH(CH3)2), 1.05 (d, J 6.9, 3H, CH(CH3)2), 0.93 (t, J 7.1, 3 H,
OCH2CH3); 13C NMR: d 213.1, 170.0, 169.2, 143.4, 137.0, 129.4, 127.4,
83.1, 64.3, 61.7, 59.6, 37.2, 27.8, 21.5, 20.9, 20.2, 19.5, 13.6; HRMS: calcd for
(9e): The ee was determined by HPLC using a Daicel Chiralpak AD
column (hexane/iPrOH 80:20): flow rate 1.0 mLminÀ1: tmajor 9.7 min;
tminor 12.4 min; t2nd diast. 7.6 and 8.6 min). 1H NMR: d 7.73 (d, J 8.0,
2H, ArH), 7.28 (d, J 8.0, 2H, ArH), 5.46 (d, J 9.9, 1H, NH), 4.67 (sep,
J 4.2, 1H, OCH(CH2)2), 4.44 (d, J 9.9, 1H, CH), 3.83 (m, 2H,
OCH2CH3), 2.81 (dq, J 18.0, J 7.2, 1H, COCH2CH3), 2.57 (m, 1H,
COCH2CH3), 2.41 (s, 3H, ArCH3), 1.85 1.63 (m, 4H, CH2), 1.61 (s, 3H,
CCH3), 1.54 1.27 (m, 6H, CH2), 1.03, (t, J 7.2, 3H, OCH2CH3), 1.03 (t,
J 7.2, 3H, COCH2CH3); 13C NMR: d 208.5, 170.4, 168.9, 143.4, 136.9,
129.4, 127.2, 74.3, 62.6, 61.7, 59.7, 33.4, 32.6, 31.1, 25.1, 23.4, 21.4, 21.0, 20.2,
13.4, 7.8; HRMS: calcd for C23H33NNaO7S: 490.1875; found: 490.1877
C22H33NO7S: 478.1875; found: 478.1872 [MNa] .
[MNa] .
Ethyl
3-(2'-oxocyclohexyl)-3-tert-butoxycarbonyl-2-(tosylamino)propa-
Ethyl 3-methyl-4-oxo-3-(diphenyl)-methoxycarbonyl-2-(tosylamino)hexa-
noate (9 f): The ee was determined by HPLC using a Daicel Chiralpak AD
column (hexane/iPrOH 90:10): flow rate 1.0 mLminÀ1: tmajor 42.6 min;
tminor 28.4 min; t2nd diast. 19.1 and 22.7 min). 1H NMR: d 7.70 (d, J 8.4,
2H, ArH), 7.38 7.25 (m, 12H, ArH), 5.41 (d, J 9.9, 1H, NH), 4.39 (d, J
9.9, 1H, CH), 3.68 (m, 2H, OCH2CH3), 2.71 (m, 1H, COCH2CH3), 2.41 (m,
1H, COCH2CH3)and (s, 3H, ArC H3), 1.67 (s, 3H, CCH3), 1.00 (t, J 7.1,
3H, OCH2CH3), 0.80 (t, J 7.1, 3H, COCH2CH3); 13C NMR: d 208.1,
170.0, 168.7, 143.5, 139.3, 139.1, 136.7, 129.4, 128.6, 128.4, 128.1, 127.3, 127.1,
126.9, 78.3, 62.6, 61.9, 59.8, 32.6, 21.4, 20.1, 13.3, 7.7; HRMS: calcd for
noate (11c): The ee was determined by HPLC using a Daicel Chiralpak
AS column (hexane/iPrOH 97:3): flow rate 1.0 mLminÀ1: tmajor 25.2 min;
tminor 33.1 min. [a]D À1.98 (c 83 mgmLÀ1, 86% ee); 1H NMR: d 7.73
(d, J 8.1, 2H, ArH), 7.29 (d, J 8.1, 2H, ArH), 5.20 (d, J 9.9, 1H, NH),
4.17 (d, J 9.7, 1H, CH), 3.86 (m, 2H, OCH2CH3), 2.94 (m, 1H, CH2), 2.41
(s, 3H, ArCH3), 2.30 (m, 3H, CH2), 2.04 (m, 1H, CH2), 1.83 (m, 1H, CH2),
1.64 (m, 2H, CH2), 1.51 (s, 9H, C(CH3)3), 0.94 (t, J 7.2, 3H, OCH2CH3);
13C NMR: d 208.3 169.5, 168.9, 143.5, 136.9, 129.4, 127.4, 83.1, 66.3, 61.7,
59.0, 40.7, 36.0, 27.8, 26.7, 21.5, 21.1, 13.6; HRMS: calcd for C22H31NNaO7S:
476.1719, found: 476.1716 [MNa] .
C30H33NNaO7S: 574.1875, found: 574.1876 [MNa] .
Ethyl 3-methyl-4-oxo-3-phenoxycarbonyl-2-(tosylamino)hexanoate (9g):
The ee was determined by HPLC using a Daicel Chiralpak AD column
Ethyl 5-phenyl-3-methyl-4-oxo-3-tert-butoxycarbonyl-2-(tosylamino)pen-
tanoate (11d): The ee was determined by HPLC using a Daicel Chiralpak
OD column (hexane/iPrOH 98:2): flow rate 1.0 mLminÀ1: tmajor 18.0 min;
tminor 21.7 min; t2nd diast. 17.0 and 20.2 min). [a]D 2.78 (c
70 mgmLÀ1, 93% ee); 1H NMR: d 7.75 (d, J 8.1, 2H, ArH), 7.30 (m,
5H, ArH), 7.29 (d, J 8.1, 2H, ArH), 5.40 (d, J 9.9, 1H, NH), 4.42 (d, J
9.9, 1H, CH), 4.09 (d, J 10.3, 1H, ArCH2CO), 3.86 (m, 3H, ArCH2CO
and OCH2CH3), 2.42 (s, 3H, ArCH3), 1.71 (s, 3H, CCH3), 1.56 (s, 9H,
C(CH3)3), 0.93 (t, J 7.1, 3H, OCH2CH3); 13C NMR: d 205.7, 169.7, 169.0,
(hexane/iPrOH 90:10): flow rate 1.0 mLminÀ1: tmajor 38.6 min; tminor
34.7 min. 1H NMR: d 7.56 (d, J 8.0, 2H, ArH), 7.40 (t, J 7.9, 2H,
ArH), 7.32 7.25 (m, 3H, ArH), 7.14 (d, J 8.0, 2H, ArH), 5.38 (d, J 10.2,
1H, NH), 4.51 (d, J 10.2, 1H, CH), 3.90 (m, 2H, OCH2CH3), 2.91 (m, 1H,
COCH2CH3), 2.56 (m, 1H, COCH2CH3), 2.42 (s, 3H, ArCH3), 1.83 (s, 3H,
CCH3), 1.08 (t, J 7.0, 3H, OCH2CH3), 0.95 (t, J 7.0, 3H, COCH2CH3);
Chem. Eur. J. 2003, 9, 2359 2367
¹ 2003 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2365